It was has a huge challenge for Nils Hoem, Aker Biomarine’s chief scientists, to understand the specifics of nutraceuticals when he first arrived at the Norwegian krill oil manufacturer in 2008 after a career in pharmaceuticals.
As global krill oil major Aker Biomarine awaits regulatory approval for its new Superba 2 product line in China, increased consumer demand for omega-3s is bringing increasingly more local suppliers to the market.
Encapsulating omega-3 supplements with sage polyphenols and gum arabic could be a more healthy and economically viable option than techniques currently used, while also opening up the possibility of boosting protein intake, research from India suggests.
Asia’s booming seaweed industry – buoyed by demand for nutraceutical, pharmaceutical, and antimicrobial products – needs to avoid the ecological and societal pitfalls experienced in agriculture and fish farming, according to a UN university institute.
India’s “shockingly low” level of EPA and DHA intake is storing up a potential health crisis, especially because life expectancy and therefore the rate of chronic illness is forecast to rise considerably over the coming decades.